United Therapeutics beats sales, earnings estimates in Q3

Shares in United Therapeutics (NSDQ:UTHR) rose today after the biotech beat expectations on Wall Street with its third quarter results.

The Silver Spring, Md.-based company posted profits of $267.3 million, or $6.28 per share, on sales of $445.5 million for the 3 months ended Sept. 30, for bottom-line growth of 71% on sales growth of 9.1% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post United Therapeutics beats sales, earnings estimates in Q3 appeared first on MassDevice.

from MassDevice http://ift.tt/2ljcl6z